Envision Healthcare Holdings (EVHC) Hits New Lifetime High Today
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.
Trade-Ideas LLC identified
(
) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Envision Healthcare Holdings as such a stock due to the following factors:
- EVHC has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $121.6 million.
- EVHC has traded 20,948 shares today.
- EVHC is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in EVHC with the Ticky from Trade-Ideas. See the FREE profile for EVHC NOW at Trade-Ideas
More details on EVHC:
Envision Healthcare Holdings, Inc. provides physician-led, outsourced medical services to consumers, hospitals, healthcare systems, health plans, and government entities in the United States. EVHC has a PE ratio of 56.8. Currently there are 11 analysts that rate Envision Healthcare Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.
The average volume for Envision Healthcare Holdings has been 1.4 million shares per day over the past 30 days. Envision Healthcare has a market cap of $6.9 billion and is part of the health care sector and health services industry. Shares are up 8.9% year-to-date as of the close of trading on Wednesday.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Analysis:
rates Envision Healthcare Holdings as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and poor profit margins.
Highlights from the ratings report include:
- Compared to where it was a year ago today, the stock is now trading at a higher level, reflecting both the market's overall trend during that period and the fact that the company's earnings growth has been robust. Looking ahead, our view is that this company's fundamentals will not have much impact in either direction, allowing the stock to generally move up or down based on the push and pull of the broad market.
- ENVISION HEALTHCARE HLDGS reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past year. We feel that this trend should continue. This trend suggests that the performance of the business is improving. During the past fiscal year, ENVISION HEALTHCARE HLDGS increased its bottom line by earning $0.66 versus $0.06 in the prior year. This year, the market expects an improvement in earnings ($1.47 versus $0.66).
- When compared to other companies in the Health Care Providers & Services industry and the overall market, ENVISION HEALTHCARE HLDGS's return on equity is below that of both the industry average and the S&P 500.
- The gross profit margin for ENVISION HEALTHCARE HLDGS is rather low; currently it is at 15.33%. Regardless of EVHC's low profit margin, it has managed to increase from the same period last year. Despite the mixed results of the gross profit margin, EVHC's net profit margin of 4.30% compares favorably to the industry average.
- The debt-to-equity ratio of 1.15 is relatively high when compared with the industry average, suggesting a need for better debt level management. Regardless of the company's weak debt-to-equity ratio, EVHC has managed to keep a strong quick ratio of 2.20, which demonstrates the ability to cover short-term cash needs.
- You can view the full Envision Healthcare Holdings Ratings Report.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
null